Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
Veeva EDC
Best for
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.
What to consider
Viedoc combines an Everest Group Leader rating with no-downtime study changes, strong certifications and a published pricing model. It has no native CTMS and no named eConsent module.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Veeva EDC vs Viedoc (EDC): category feature evidence and sources. Products are not ranked.
Category feature
Veeva EDC
Viedoc
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Veeva EDC
Supported
Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.
The vendor reports study, participant and site adoption across a stated country count.
Study build and mid-study changesFeature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Veeva EDC
Supported
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
A self-service designer and database updates without downtime are both stated.
Compliance and securityFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Veeva EDC
Supported
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
Connected clinical applications are listed; native medical coding is not established in this note.
Viedoc
Extended support
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.
Native randomization, trial supply, medical coding and ePRO are all named.
APIs and data standardsFeature definitions
Supported
An API for clinical data exchange is stated.
Extended support
An API plus data exchange in a named CDISC format are documented.
Veeva EDC
Supported
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.